Recombinant Mouse Anti-MNV Antibody (A6.2, 22) (CAT#: PABL-275)

Recombinant Mouse Antibody (A6.2, 22) is capable of binding to MNV, expressed in Chinese Hamster Ovary cells (CHO).

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Published Data
  • Datasheet
  • MSDS
  • COA

Figure 1 MNV-1 was passaged 5 times through RAW 264.7 cells in the presence of increasing concentrations of the neutralizing MAb A6.2 or a nonneutralizing isotype control antibody. Passage 0 (P0) virus, P3 virus grown with MAb A6.2, and P5 viruses from both conditions were then analyzed in a neutralization assay with 0, 20, 60, and 200 ng MAb A6.2.

Figure 1 MNV-1 was passaged 5 times through RAW 264.7 cells in the presence of increasing concentrations of the neutralizing MAb A6.2 or a nonneutralizing isotype control antibody. Passage 0 (P0) virus, P3 virus grown with MAb A6.2, and P5 viruses from both conditions were then analyzed in a neutralization assay with 0, 20, 60, and 200 ng MAb A6.2.

Kolawole, A. O., Li, M., Xia, C., Fischer, A. E., Giacobbi, N. S., Rippinger, C. M.,... & Yu, C. (2014). Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization. Journal of virology, 88(8), 4543-4557.

Figure 2 Mutations in the E′F′ loop of the P domain mediate MNV-1 escape from MAb A6.2 neutralization in culture.

Figure 2 Mutations in the E′F′ loop of the P domain mediate MNV-1 escape from MAb A6.2 neutralization in culture.

WT MNV and nine A′B′ loop single point mutants (A), nine E′F′ loop single point mutants (B), and three naturally occurring mutants as well as one double mutant (C) were subjected to in vitro MAb A6.2 neutralization. Virus was incubated with indicated concentrations of MAb A6.2 for 30 min at 37°C before infection of RAW 264.7 cells. Viral titers were measured by plaque assay. Percent infectivity of virus titers at different concentrations of MAb A6.2 was calculated relative to the control without MAb A6.2 set to 100%.

Kolawole, A. O., Li, M., Xia, C., Fischer, A. E., Giacobbi, N. S., Rippinger, C. M.,... & Yu, C. (2014). Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization. Journal of virology, 88(8), 4543-4557.

Figure 3 Mutations in the E′F′ loop of the MNV-1 P domain mediate escape from MAb A6.2 neutralization in mice.

Figure 3 Mutations in the E′F′ loop of the MNV-1 P domain mediate escape from MAb A6.2 neutralization in mice.

STAT1−/− mice were simultaneously infected with 106 PFU of the indicated recombinant MNV-1 orally and injected with MAb A6.2 (open box) or isotype control MAb (black box) intraperitoneally. Virus titers were measured 48 h postinfection in indicated tissues from animals infected with the wild type (A) or one of the Q298E (B), S299A (C), A382K (D), A382R (E), or L386F (F) mutants with 500 μg MAb, WT-infected animals injected with 15 (G) and 100 (H) μg MAb, and L386F mutant-infected animals injected with 15 (I) and 100 (J) μg MAb, respectively. Data are presented as means ± standard deviations (SD) from at least five mice per condition from at least two independent experiments. Statistical analysis was performed using the t test to compare the virus titer for each tissue between MAb A6.2-injected mice and the isotype control.

Kolawole, A. O., Li, M., Xia, C., Fischer, A. E., Giacobbi, N. S., Rippinger, C. M.,... & Yu, C. (2014). Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization. Journal of virology, 88(8), 4543-4557.

Figure 4 Binding of recombinant MNV-1 P-domains to MAb A6.2.

Figure 4 Binding of recombinant MNV-1 P-domains to MAb A6.2.

ELISA plates were coated overnight at 4°C with bacterially expressed, recombinant MNV-1 P domain A′B′ loop (A) and E′F′ loop (B) mutants at 50 μg/ml in each well. Diluted purified MAb A6.2 followed by secondary antibodies was incubated for 60 min at 37°C. MNV.CR3 P domain was used as a negative control. Data are presented as means ± SE from three independent experiments. The three bars in each set of bars represent three dilutions of purified MAb A6.2: 1, 0.1, and 0.01 μg/ml.

Kolawole, A. O., Li, M., Xia, C., Fischer, A. E., Giacobbi, N. S., Rippinger, C. M.,... & Yu, C. (2014). Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization. Journal of virology, 88(8), 4543-4557.

Figure 5 Neutralization of MNV by MAb and Fab A6.2.

Figure 5 Neutralization of MNV by MAb and Fab A6.2.

Equal amounts of MNV were incubated with MAb 6.2, its Fab fragment, or an isotype control antibody and analyzed in a plaque neutralization assay. The assay was repeated twice, and plaque assays were performed in duplicate to calculate standard deviations.

Katpally, U., Wobus, C. E., Dryden, K., Virgin, H. W., & Smith, T. J. (2008). Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles.Journal of virology, 82(5), 2079-2088.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG
  • Specificity
  • Tested positive against native MNV MNV
  • Species Reactivity
  • MNV
  • Clone
  • A6.2, 22
  • Applications
  • WB, ELISA, Neut, FuncS

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The antibody was validated for ELISA, Neutralization and Function Assay. For details, refer to Published Data.

Target

  • Alternative Names
  • Murine norovirus; MNV

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone A6.2, 22"

See other products for "MNV"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Fab Antibody Products ScFv Antibody Products
CAT Product Name Application Type
MOB-669 Recombinant Anti-MNV Antibody WB, IF, FuncS IgG
MHH-669 Recombinant Human Anti-MNV Antibody ELISA, WB, Dot, FuncS IgG

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for PABL-275. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare